news release
- company news
recently, our company on hypertension line, preferred drug yitai® perindopril tert-butylamine tablets and shangyao dongying ( jiangsu ) pharmaceutical co., ltd. to reach a strategic cooperation, access to the product exclusive national agency.
morewe have recently entered into a partnership with fuso teikoku qingdao co.,
morerecently, we have received the supplementary drug application approval from the nmpa for amoxicillin - amoxicillin capsules (0.25 g, 0.5 g) and greats® - irbesartan tablets (75 mg). the products have passed the generic drug consistency evaluation, in
moreshionogi completed the acquisition of sumitomo corporation’s 29% stake in c&o in december 2019. upon completion of the acquisition, shionogi became the sole shareholder with shareholding of 100% held in c&o.
more2019 president shionogi award - fast-growing aobo ping
morefrom july 31 to august 2, the 54th national new drug fair was held in shenyang international exhibition center......
more
address5/f, jihao building, 1086 shennan east road, luohu district, shenzhen
adverse drug reactions / event feedback hotline025-6816 1304
adverse drug reactions / event feedback mailgvp@changao.com
official wechat account mobile page